{"id":64213,"date":"2025-01-31T12:01:36","date_gmt":"2025-01-31T12:01:36","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/01\/31\/sab-bio-to-participate-in-upcoming-investor-conferences\/"},"modified":"2025-01-31T12:01:36","modified_gmt":"2025-01-31T12:01:36","slug":"sab-bio-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"SAB BIO to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">MIAMI, Jan.  31, 2025  (GLOBE NEWSWIRE) &#8212; SAB BIO (Nasdaq:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=biYqkYnNSG_Lo6A1wWn1kwgvYUaXAjAyPWt1pqJndj_rQhrhgJa5i9xszmjq7lMhpqPHpzQa7mNpXFIFJqjmCnBJgKephQu62klfsdQdoi5QoI-UnAt-Sd8BxEsYadmyQePqzG0Lp2PI8PRkDXAaFFCif75bG68wcnaqeg5rJg_kzzTNl4_bEcuuak5h1C-2oMoDBD4I4mez9kQ7lFPdUfg8Goyj6DOyitguluhL37RAr08xFwThckst1AQ39vwsW9XKdSkJdNEEi2qaCZQdt0HFIJn_VhHzSPaq6AI5ull9Fm43Ro6MFeFAfg0JHqyWO_-SDV0e4LCGgm6yS5-4ysGwgnWofLGteZsWVViaBgFzCpLOcaD2eNMVmGGBWp72evqTqAjmz3bUOPXSBZVALzKGXpWllfVPz8Oa3Xi6OJ5xjLGNxbsEVy-MjnjgaCKMQlHwuGD4u_iMdCpm1hgdwyFPbDWZ46Z0EWhdvVCAplpboNyFDyNLygSVi9knyP4wiUkuOnX7yFIyGGsOcumO7Z1jzRSvOebkV37lmKgoGgiszsibcMx9jvDljIfRmqu-x9BhmZGV7dzEkOSGvzEK4YccRBTwMJU52yZwMR1AbJR-6CVoV6B-EVt4xim_cU0Fl-ju6VeBL0aZ0WNnfHdWNxQt0P_yyjhqTuZYi5jcRs4ilSIjNvAvEjQy66wYJ4F1DuM2bjLTBTyq_o1800EBML4TChgTLDxC42m7AVY76keuxP4xEqEGCu1HCypS_UyIkgL71TeIX9T47b8KPNfsWnRWZLTYVAEBldEt3p3tFlECgw4DUgKLgLA1QDEhGUBWof3GX1ttfmZY7B6J-QIVaIJTlX_AGWs3W0Qo5EubHYJV7A3NMuSXwV0i1Dw-Fr7V1E1iYBF1uj9IqdIjqK7YqoaPTKCs1_Wcsk8huhRELurMgHMJnT44IXp-QHbWkO7lcEv97Hz5blANqzPq6EhV0_0M_3rTvgkwBCajc01xMh0iq4z09-bXOJzw9Mfav4O9yshvWZv6qwFU9xnX9GIk2Sm1J10QggPhe10mtQJ8KdYGXAMXF9s3d6Lkdw8PaFqdve9V9qPoBaKnhkkx04viZQeFNIAfuZ8BXRGONLk-GYRhtcVZZZ58Asz-gEYNLUzaEg7EpF6tdcNm2XShdezp9JXenk-AfVV4r8R3C2dTIY_mJQWcOORE3sRIR14t4nZTuBbJqH1qHOVMy0Shh0Ags3PEyZBVqktpJP5eoEtYHoGEuzsqcgxax9jsOmqKgoBMioGNuzAD7NFUFX7MlaphNHG2Das9xYa9-EcMXitPM100zqQ7T6BJHeUlJmaJ5AvwdKUnYawvaFYlenghKTIpw7vFQCmGEgf7a5RAa2VOORER5dY3bDsx9kWlhSw4Lvw2V3ZH1lAq-va9Ug_ap7r0WPjBFksC2LAf41-4OHS8q_9ha3JupafmOh2monAYvjTosxOMMWMVoz0LZg6Qtx2-Vg==\" rel=\"nofollow\" target=\"_blank\" title=\"SABS\">SABS<\/a>), (\u201cSAB BIO\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing SAB-142, a human anti-thymocyte immunoglobulin (hIgG) that potentially delays the onset or progression of type 1 diabetes (T1D), today announced that members of its management team will participate in the following investor conferences:<\/p>\n<p><strong>Event:\u00a0<\/strong>Guggenheim SMID Cap Biotech Conference<br \/><strong>Date:\u00a0<\/strong>February 6, 2025<br \/><strong>Fireside Chat:\u00a0<\/strong>2:00 \u2013 2:25pm ET<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8EK9zVC4MXuZjbnTEJkzp2oaX089IJ5j4-dTIeSvCRjU3Qpu5lLRvfdbuwGwNcEPWmqyaKtWqNp6F7HY8eFAtJrCKtJYvNqKSpZ_UIept8LFNoZcsyvcX2PPXWIaLKV4Hi-Z9WtFSkdhWkxW3UKFiT2Gvxx6Dpmd-kc7OzD-nMBiUbst3NIS-IHwVngUOVGeybfdUkmzk7XA3Wf9mQKUtSwRLcpTuQQXUJnrkxkyps_q-OKUwPoUGFVZMawCFQkOm-RJen3MtJ-EWMC9Yk_iHRwsfF7EZPPBmAtgHuU151GPJDI8YWCgo01xEXyFTldCM97wCdXp6sYYrh8vY4OgGdQBVUtsGVIK4X627Z2HoDDXxMBOaYPFeganqJ5TzjsU99iq3dRAm5aGXBlq8rrJsKAGzgngm9S3YPp2R51EfYs219XsZvQVqrlgk4y5QTVKMay7CFbE0TlqkoBPIe9iLaqf6ejAOSrscZGYStaq4eHVzY909pzrv58xYCmbvs9kJRnFYkWRoTXXiqq7uD0ZJdnZXOSweHe3sPgWZfirTch6WnR5A-DmE2smEy_VJTzV60IQpNFfQFkFlAelqse4CRHnN7RVYJkAzEjxisQKrCm8Jjup4XQlBAUi-bySn0BpejoP3rsKQb9Wo7BbMmeH8Cw7j1lv6oAiycm9CSYsWX4=\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/wsw.com\/webcast\/guggen2\/sabs\/1999239<\/a><\/p>\n<p><strong>Event:\u00a0<\/strong>Oppenheimer 35<sup>th<\/sup>\u00a0Annual Healthcare Life Sciences Conference<br \/><strong>Date:\u00a0<\/strong>February 12, 2025<br \/><strong>Company Presentation: <\/strong>10:00 \u2013 10:30am ET<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8EK9zVC4MXuZjbnTEJkzp2oaX089IJ5j4-dTIeSvCRiojyf1yNbyYQNlZZ8JFrorU4-mbudRxR_gPs_tDHF8rQLCrON9h9YfGHtlQhjwX2AqZQ6B7dT7kmpLJj6hGFKfvILAnjIlP86QfamXSZ6q_EpAU_20LfT5UOaY8THAJvpgU9P027xfOHOPVPSdTYBJ0EUsKsZutWYo7aeGzGwH9tvZCi0JaAQXsC4-vWhZxSm0UoPqqMn9knUq78iRJEmpvRN--bMawzW26zTzXnQPFSiznqDvmz07J0XrCOZx1rDCDUNVBCudP2grPyBhK8HJseCb1JkQKDHLlQh0m3d3C3An3ZRrjivTWJZKmB4-GReGjNyisjaaqZichsw5ufAXRYjOhMAM33zP6KzpN3xOfORQDmze-oXTr-pkWgr7EXI8q1VsdFoCeD6mYMDiXZIer856v1FeNqtOOWpjbd0IpfXceyrsp2imtPvVPLKxVZoU4PmMHDkcU3-dveeTL9Wt90o0AwrWBmlAWWA-1JCLObHiFhAlchgXQVg3Idtq0v4l79h3-2_ZWeqVxn-6BItAshnz4kEFw65G3zQjW2gZeheeCAME7f3ULQzNq5tpwRbfUK9kfE0mhdmUFi5NecnJ050WsXlzp5HdBsiZzJDasnxDrmh6p4grKEDlB5PkFoOMZZwgu7T12dELU_J3VKsq\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/wsw.com\/webcast\/oppenheimer39\/sabs\/2773928<\/a><\/p>\n<p>Access to the live webcasts of these events, as well as archived recordings, will be available under the \u201cEvents\u201d tab on the investor relations section of the SAB BIO website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8EK9zVC4MXuZjbnTEJkzp2h4gys7jCiP1p-QqixUU2NHtGIl-4wQD4fFy2I23vq8zvRXPUQK5LahpD8AmYtGQLOOR84jqhQGfa_2khpxcsffbN4YAw8QIIJJ4XH7_iwOTK6UaMEiTShjATW5Jni-Og==\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/ir.sab.bio\/news-events\/events<\/a>.<\/p>\n<p><strong>About SAB BIO<\/strong><\/p>\n<p>SAB BIO (SAB) is a clinical-stage biopharmaceutical company focused on developing human, multi- targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma, to treat and prevent immune and autoimmune disorders. The Company\u2019s lead asset, SAB-142, targets T1D with a disease-modifying therapeutic approach that aims to change the treatment paradigm by delaying onset and potentially preventing disease progression. Using advanced genetic engineering and antibody science to develop Transchromosomic (Tc) Bovine&#x2122;, the only transgenic animal with a human artificial chromosome, SAB\u2019s DiversitAb&#x2122; drug development production system is able to generate a diverse repertoire of specifically targeted, high-potency, human IgGs that can address a wide range of serious unmet needs in human diseases without the need for convalescent plasma or human donors. For more information on SAB, visit: https:\/\/www.SAB.bio\/ and follow SAB on Twitter and LinkedIn.<\/p>\n<p><strong>Forward-Looking Statements<\/strong><\/p>\n<p>Certain statements made in this current report that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as \u201cbelieve,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cto be,\u201d \u201cestimate,\u201d \u201ccontinue,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201cplan,\u201d \u201cpredict,\u201d \u201cpotential,\u201d \u201cseem,\u201d \u201cseek,\u201d \u201cfuture,\u201d \u201coutlook,\u201d and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, including, the data, development, clinical results, and efficacy of our T1D program and other discovery programs.<\/p>\n<p>These statements are based on the current expectations of SAB BIO and are not predictions of actual performance, and are not intended to serve as, and must not be relied on, by any investor as a guarantee, prediction, definitive statement, or an assurance, of fact or probability. These statements are only current predictions or expectations, and are subject to known and unknown risks, uncertainties and other factors which may be beyond our control. Actual events and circumstances are difficult or impossible to predict, and these risks and uncertainties may cause our or our industry\u2019s results, performance, or achievements to be materially different from those anticipated by these forward-looking statements. A further description of risks and uncertainties can be found in the sections captioned \u201cRisk Factors\u201d in our most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, as may be amended or supplemented from time to time, and other filings with or submissions to, the U.S. Securities and Exchange Commission, which are available at https:\/\/www.sec.gov\/. Except as otherwise required by law, SAB BIO disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events, or circumstances or otherwise.<\/p>\n<p><strong>CONTACTS<\/strong><\/p>\n<p>Media Relations:<\/p>\n<p><strong>Kaelan Hollon<\/strong><\/p>\n<p>Vice President of Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vDbp523BIemRFEN0NxK1JOyjXjB3DH3duSHuiVQqIC1ghPwzRmyOpaxDyZCuBpQ3WjZHv17iMYbiBEHob2Dw9w==\" rel=\"nofollow\" target=\"_blank\" title=\"khollon@sab.bio\">khollon@sab.bio<\/a><\/p>\n<p>Investor Relations:<br \/><strong>Kevin Gardner<\/strong><br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uYc0INslmWAFpv6NjuHT59ccgV_hNTqDA8A1lL_FzI-VRpt4Jpq1GKY4e_bxjeMnOCmWno00fMxpvu16NpPfUdQyA_H0lE15IOYJmqThdzUbP_LT1dT89vFb1r86MGVS\" rel=\"nofollow\" target=\"_blank\" title=\"kgardner@lifesciadvisors.com\">kgardner@lifesciadvisors.com<\/a><\/p>\n<p><strong>Chris Calabrese<\/strong><br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CHX6hs1ufJr4YXshmE0tdJTMCNVazBw_T5cOv5N0nh1G_Ys8shnLBv8m8U8J95HLFyrpH_kSG8R0pIcPJXNfN_ocXumK3jd6SRaPWzlBVmgiMiEddkM_FOrEEVAHR332\" rel=\"nofollow\" target=\"_blank\" title=\"ccalabrese@lifesciadvisors.com\">ccalabrese@lifesciadvisors.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzI4YzI3NjAtMTViYS00YmUwLWFiZTMtNWRjZDRhNzg3MTg0LTEyMzMyOTQ=\/tiny\/SAB-Biotherapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; SAB BIO (Nasdaq:\u00a0SABS), (\u201cSAB BIO\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing SAB-142, a human anti-thymocyte immunoglobulin (hIgG) that potentially delays the onset or progression of type 1 diabetes (T1D), today announced that members of its management team will participate [&#8230;]\n","protected":false},"author":1,"featured_media":64214,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64213","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SAB BIO to Participate in Upcoming Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SAB BIO to Participate in Upcoming Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; SAB BIO (Nasdaq:\u00a0SABS), (\u201cSAB BIO\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical compan\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-31T12:01:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/SAB-Biotherapeutics-Inc-1-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"SAB BIO to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-01-31T12:01:36+00:00\",\"dateModified\":\"2025-01-31T12:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\"},\"wordCount\":647,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\",\"name\":\"SAB BIO to Participate in Upcoming Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-01-31T12:01:36+00:00\",\"dateModified\":\"2025-01-31T12:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SAB BIO to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SAB BIO to Participate in Upcoming Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"SAB BIO to Participate in Upcoming Investor Conferences","og_description":"MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; SAB BIO (Nasdaq:\u00a0SABS), (\u201cSAB BIO\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical compan","og_url":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-01-31T12:01:36+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/SAB-Biotherapeutics-Inc-1-2.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"SAB BIO to Participate in Upcoming Investor Conferences","datePublished":"2025-01-31T12:01:36+00:00","dateModified":"2025-01-31T12:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/"},"wordCount":647,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/","name":"SAB BIO to Participate in Upcoming Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-01-31T12:01:36+00:00","dateModified":"2025-01-31T12:01:36+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/sab-bio-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"SAB BIO to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64213"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64213\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64214"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}